Gene: SULT1C2
Official Full Name: sulfotransferase family 1C member 2provided by HGNC
Gene Summary: Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs, and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members. This gene encodes a protein that belongs to the SULT1 subfamily, responsible for transferring a sulfo moiety from PAPS to phenol-containing compounds. Two alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13646 | SULT1C2 Knockout cell line (HCT 116) | Human | SULT1C2 | 1:2~1:4 | Negative | Online Inquiry |
SULT1C2 Gene Knockout Cell Lines are specifically engineered cellular models in which the SULT1C2 gene has been inactivated through targeted gene editing techniques, such as CRISPR-Cas9. These cell lines play a crucial role in studying the physiological and pharmacological functions of the SULT1C2 gene, which encodes a sulfotransferase involved in the metabolism of various endogenous compounds and xenobiotics. By knocking out this particular gene, researchers can effectively explore its impact on cellular processes, drug metabolism, and signaling pathways, enhancing our understanding of how sulfate conjugation affects biochemical responses.
In terms of functionality, the SULT1C2 knockout cell lines allow for the precise assessment of gene function and can be utilized in high-throughput screening assays to study the effects of potential drug candidates. These models are vital for elucidating the mechanisms of drug disposition and the metabolic pathways involved in detoxification processes, thus revealing insights into both therapeutic and adverse drug reactions.
The scientific significance of SULT1C2 gene knockout cell lines is underscored in various domains, including pharmacogenomics, toxicology, and cancer research. Clinically, they can serve as predictive tools to identify patient-specific responses to medications that are substrates for sulfotransferases, emphasizing their potential utility in personalized medicine strategies.
What sets these knockout cell lines apart from alternatives is their specificity and robustness; they have undergone rigorous validation to confirm the complete loss of SULT1C2 activity. This specificity ensures that experimental outcomes directly attributable to this gene mutation enhance the reliability of research findings.
For researchers and clinicians, acquiring SULT1C2 gene knockout cell lines is a valuable investment into advancing the understanding of drug metabolism and personalized therapeutics. Their integration into experimental workflows enables high-quality data generation and can lead to breakthroughs in drug development processes.
Our company specializes in providing high-quality biological products that are essential for cutting-edge research. We stand by the integrity and performance of our offerings, ensuring that your research is supported by reliable and validated cell line models.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.